Aβ Modulation: The Next Generation of AD Therapeutics
- 25 January 2006
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 920 (1) , 269-273
- https://doi.org/10.1111/j.1749-6632.2000.tb06935.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Modulation of amyloid β protein precursor processing as a means of retarding progression of Alzheimer’s diseaseJournal of Clinical Investigation, 1999
- The Presenilins in Alzheimer's Disease--Proteolysis Holds the KeyScience, 1999
- Rationalizing a pharmacological intervention on the amyloid precursor protein metabolismTrends in Pharmacological Sciences, 1999
- Cellular mechanisms of β-amyloid production and secretionProceedings of the National Academy of Sciences, 1999
- Are Presenilins Intramembrane-Cleaving Proteases? Implications for the Molecular Mechanism of Alzheimer's DiseaseBiochemistry, 1999
- Translating cell biology into therapeutic advances in Alzheimer's diseaseNature, 1999
- A Review of Quality of Life in Alzheimer???s DiseasePharmacoEconomics, 1999
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996